enGene Therapeutics Inc. Warrants (NASDAQ: ENGNW) last traded at $0.430, up 71.90% on the session. The quote above updates while this page is open; the figures below are drawn from enGene Therapeutics Inc. Warrants’s own filings and are restated only when a new one is published.
enGene Therapeutics Inc. Warrants trades on NASDAQ under the ticker ENGNW. Its market capitalisation is $28.81 million.
Valuation measures for enGene Therapeutics Inc. Warrants, derived from the latest quote and its most recent SEC filing.
| Market cap | $28.81M |
|---|---|
| Enterprise value | $51.34M |
| P/E ratio | 0.18 |
| Price / book | 0.11 |
Trailing-twelve-month figures tagged in enGene Therapeutics Inc. Warrants's XBRL filings with the SEC.
| Net income (TTM) | -$126.85M |
|---|---|
| EPS (TTM) | $2.33 |
| Return on equity | -49.71% |
| Cash | $29.83M |
Range and volume for ENGNW over the past 52 weeks.
| 52-week high | $0.430 |
|---|---|
| 52-week low | $0.252 |
| Volume | 2.4K |
| Average volume | 2.4K |
| Previous close | $0.250 |
Dividend history for enGene Therapeutics Inc. Warrants over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
| Payout ratio | 0.00% |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.